Market Overview

UPDATE: Bank of America Raises PO to $6.75 on Tenet Healthcare on Value-Adding Actions

Share:
Related THC
CNBC's Stock Pops & Drops From May 5
Will Tenet Healthcare Report Healthy Results? The Street & Crowd Weigh In
Tenet Healthcare (THC) Trevor Fetter on Q1 2015 Results - Earnings Call Transcript (Seeking Alpha)

Bank of America reiterated its Neutral rating on Tenet Healthcare (NYSE: THC) and raised its price objective from $6 to $6.75 a share.

Bank of America said, "his morning THC announced a number of items with the goal of enhancing shareholder value including: 1) a reverse 1 for 4 stock split, 2) a $500m share repo authorization, 3) an outlook of $400m in deals, and 4) a new bond offering. We are always a bit skeptical of the shareholder value enhancing aspects of a reverse stock split (especially when the company apparently thinks that its stock was going up anyway), but the commitment to deploy capital is a welcome sight and should provide some support for the shares. This morning we are raising our PO to $6.75 from $6 to reflect the more aggressive plans for capital deployment, although we continue to see more upside elsewhere in hospitals."

Tenet Healthcare closed at $6.27 on Friday.

Latest Ratings for THC

DateFirmActionFromTo
Mar 2015SunTrust Robinson HumphreyMaintainsNeutral
Mar 2015BMO CapitalDowngradesOutperformMarket Perform
Feb 2015CitigroupMaintainsBuy

View More Analyst Ratings for THC
View the Latest Analyst Ratings

Posted-In: Bank of AmericaAnalyst Color Price Target Intraday Update Analyst Ratings

 

Related Articles (THC)

Around the Web, We're Loving...